Evidence map›Paper›PMID 40810051›Full record

ReviewEnvironmental systems research2025

PFAS in water environments: recent progress and challenges in monitoring, toxicity, treatment technologies, and post-treatment toxicity.

Aya Alsadik, Olufemi Oluseun Akintunde, Hamid R Habibi, Gopal Achari

Abstract readReview
In one paragraph

Review in Environmental systems research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aya AlsadikDepartment of Civil Engineering, University of Calgary, ENE 231, 2500 University Drive NW, Calgary, AB T2N 1N4 Canada.
Olufemi Oluseun AkintundeDepartment of Civil Engineering, University of Calgary, ENE 231, 2500 University Drive NW, Calgary, AB T2N 1N4 Canada.
Hamid R HabibiDepartment of Biological Sciences, University of Calgary, 577A, 2500 University Drive NW, Calgary, AB T2N 1N4 Canada.
Gopal AchariDepartment of Civil Engineering, University of Calgary, ENE 231, 2500 University Drive NW, Calgary, AB T2N 1N4 Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is growing awareness of the environmental presence of per- and polyfluoroalkyl substances (PFAS) and their harmful effects on animals and humans. Recent studies have revealed changes in human embryonic stem cells and maternal biomarkers, underscoring the severity and unpredictable outcomes associated with long-term exposure to PFAS. Monitoring efforts continually identify additional PFAS compounds worldwide, but a standardized and unified approach is still lacking. Traditional treatment methods such as adsorption and membrane filtration have been effective in removing 80-95% of PFAS from wastewater. However, complete removal of short-chain PFAS remains limited to a few recently developed techniques. The inability of advanced treatment methods to eliminate emerging short-chain and ultrashort-chain PFAS suggests the need for more integrated approaches that target all PFAS classes. Additionally, a few studies have discussed the potential toxicity outcomes of these treatments at both laboratory and full-scale levels. While advanced oxidative processes (AOPs) are rapidly gaining attention for degrading 90-100% of PFAS in sewage, it remains challenging to fully break down PFAS into non-toxic, mineralized products such as CO Supplementary Information: The online version contains supplementary material available at 10.1186/s40068-025-00411-9.

Indexed as

MonitoringPFASReviewToxicityTreatment technologies

Identifiers

PMID40810051
PMCPMC12339656

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.